Abstract:Motivation: Computational drug repositioning is an important and efficient approach towards identifying novel treatments for diseases in drug discovery. The emergence of large-scale, heterogeneous biological and biomedical datasets has provided an unprecedented opportunity for developing computational drug repositioning methods. The drug repositioning problem can be modeled as a recommendation system that recommends novel treatments based on known drug-disease associations. The formulation under this recommendation system is matrix completion, assuming that the hidden factors contributing to drug-disease associations are highly correlated and thus the corresponding data matrix is low-rank. Under this assumption, the matrix completion algorithm fills out the unknown entries in the drug-disease matrix by constructing a low-rank matrix approximation, where new drug-disease associations having not been validated can be screened.Results: In this work, we propose a drug repositioning recommendation system (DRRS) to predict novel drug indications by integrating related data sources and validated information of drugs and diseases. Firstly, we construct a heterogeneous drug-disease interaction network by integrating drug-drug, disease-disease and drug-disease networks. The heterogeneous network is represented by a large drug-disease adjacency matrix, whose entries include drug pairs, disease pairs, known drug-disease interaction pairs and unknown drug-disease pairs. Then, we adopt a fast Singular Value Thresholding (SVT) algorithm to complete the drug-disease adjacency matrix with predicted scores for unknown drug-disease pairs. The comprehensive experimental results show that DRRS improves the prediction accuracy compared with the other state-of-the-art approaches. In addition, case studies for several selected drugs further demonstrate the practical usefulness of the proposed method.Availability and implementation: http://bioinformatics.csu.edu.cn/resources/softs/DrugRepositioning/DRRS/index.html.Contact: yaohang@cs.odu.edu or jxwang@mail.csu.edu.cn.Supplementary information: Supplementary data are available at Bioinformatics online.

Machine learning for drug repositioning: Recent advances and challenges

Machine Learning and Deep Learning Strategies in Drug Repositioning

Biomedical Data and Computational Models for Drug Repositioning: a Comprehensive Review

Deep learning in target prediction and drug repositioning: Recent advances and challenges

Network-Based Approaches for Drug Repositioning.

A machine learning approach to drug repositioning based on drug expression profiles: Applications to schizophrenia and depression/anxiety disorders

A Computational Strategy for Drug Repositioning Based on Support-Vector Regression Algorithm

Machine Learning Applications in Drug Repurposing

What are the current challenges for machine learning in drug discovery and repurposing?

Computational drug repositioning using low-rank matrix approximation and randomized algorithms

A Novel Drug Repositioning Approach Based on Collaborative Metric Learning

Computational Drug Repositioning Using Collaborative Filtering Via Multi-Source Fusion

Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics

A Review of Recent Developments and Progress in Computational Drug Repositioning.

A Study on Methodologies of Drug Repositioning Using Biomedical Big Data: A Focus on Diabetes Mellitus

Drug Repositioning Based on Multi-View Learning with Matrix Completion

Computational Approaches for Predicting Drug-Disease Associations: A Comprehensive Review

Recent advances in drug repurposing using machine learning

DrugRepPT: a Deep Pre-Training and Fine-Tuning Framework for Drug Repositioning Based on Drug's Expression Perturbation and Treatment Effectiveness.

DrugReAlign: a multisource prompt framework for drug repurposing based on large language models

Review of Drug Repositioning Approaches and Resources